ADME Optimization and Toxicity Assessment in Early- and Late-Phase Drug Discovery

E-ISSN： 1873-4294|9|11|965-980

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.9, Iss.11, 2009-08, pp. : 965-980

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic: ADME and Toxicity in Early Drug Discovery)

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 11, 2013-06 ,pp. : 1255-1256

Bentham Science Publishers

Access to resources Recommend Favorite

The New Pre-Preclinical Paradigm: Compound Optimization in Early and Late Phase Drug Discovery

Current Topics in Medicinal Chemistry, Vol. 1, Iss. 5, 2001-11 ,pp. : 353-366

Bentham Science Publishers

Access to resources Recommend Favorite

Improving Early Drug Discovery through ADME Modelling: An Overview

By Wishart David S.

Drugs in R&D, Vol. 8, Iss. 6, 2007-01 ,pp. : 349-362

Adis International

Access to resources Recommend Favorite

Early ADME in Support of Drug Discovery: The Role of Metabolic Stability Studies

Current Drug Metabolism, Vol. 1, Iss. 3, 2000-11 ,pp. : 215-241

Bentham Science Publishers

Access to resources Recommend Favorite

In-Silico ADME Models: A General Assessment of their Utility in Drug Discovery Applications

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 4, 2011-02 ,pp. : 358-381

Bentham Science Publishers

Access to resources Recommend Favorite